These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 20484099)
1. Long-term outcome of adjunctive celecoxib treatment after paclitaxel-eluting stent implantation for the complex coronary lesions: two-year clinical follow-up of COREA-TAXUS trial. Chung JW; Yang HM; Park KW; Lee HY; Park JS; Kang HJ; Cho YS; Youn TJ; Koo BK; Chae IH; Choi DJ; Oh BH; Park YB; Kim HS Circ Cardiovasc Interv; 2010 Jun; 3(3):243-8. PubMed ID: 20484099 [TBL] [Abstract][Full Text] [Related]
2. Effects of celecoxib on restenosis after coronary intervention and evolution of atherosclerosis (Mini-COREA) trial: celecoxib, a double-edged sword for patients with angina. Kang HJ; Oh IY; Chung JW; Yang HM; Suh JW; Park KW; Kwon TK; Lee HY; Cho YS; Youn TJ; Koo BK; Kang WY; Kim W; Rha SW; Bae JH; Chae IH; Choi DJ; Kim HS Eur Heart J; 2012 Nov; 33(21):2653-61. PubMed ID: 22408034 [TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL; Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853 [TBL] [Abstract][Full Text] [Related]
4. TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions. Grube E; Dawkins KD; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Buellesfeld L; Koglin J; Russell ME Eur Heart J; 2007 Nov; 28(21):2578-82. PubMed ID: 17938126 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME; Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586 [TBL] [Abstract][Full Text] [Related]
6. Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study. Koo BK; Kim YS; Park KW; Yang HM; Kwon DA; Chung JW; Hahn JY; Lee HY; Park JS; Kang HJ; Cho YS; Youn TJ; Chung WY; Chae IH; Choi DJ; Oh BH; Park YB; Kim HS Lancet; 2007 Aug; 370(9587):567-74. PubMed ID: 17707751 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW; J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247 [TBL] [Abstract][Full Text] [Related]
8. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME; Circulation; 2004 Apr; 109(16):1942-7. PubMed ID: 15078803 [TBL] [Abstract][Full Text] [Related]
9. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions. Silber S; Colombo A; Banning AP; Hauptmann K; Drzewiecki J; Grube E; Dudek D; Baim DS Circulation; 2009 Oct; 120(15):1498-504. PubMed ID: 19786634 [TBL] [Abstract][Full Text] [Related]
10. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011 [TBL] [Abstract][Full Text] [Related]
11. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation. Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547 [TBL] [Abstract][Full Text] [Related]
12. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial. Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C; Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666 [TBL] [Abstract][Full Text] [Related]
13. Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I. Büllesfeld L; Gerckens U; Müller R; Grube E Z Kardiol; 2003 Oct; 92(10):825-32. PubMed ID: 14579046 [TBL] [Abstract][Full Text] [Related]
14. Comparison of long-term clinical outcome after successful implantation of Firebird sirolimus- and Taxus paclitaxel-eluting stents in Chinese population: analysis of a large single center registry. Dou KF; Xu B; Yang YJ; Chen JL; Qiao SB; Wang Y; Li JJ; Qin XW; Yao M; Liu HB; Wu YJ; Chen J; Yuan JQ; You SJ; Li W; Gao RL Chin Med J (Engl); 2010 Apr; 123(7):810-5. PubMed ID: 20497669 [TBL] [Abstract][Full Text] [Related]
15. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. Hermiller JB; Raizner A; Cannon L; Gurbel PA; Kutcher MA; Wong SC; Russell ME; Ellis SG; Mehran R; Stone GW; J Am Coll Cardiol; 2005 Apr; 45(8):1172-9. PubMed ID: 15837245 [TBL] [Abstract][Full Text] [Related]
16. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial. Moses JW; Mehran R; Nikolsky E; Lasala JM; Corey W; Albin G; Hirsch C; Leon MB; Russell ME; Ellis SG; Stone GW J Am Coll Cardiol; 2005 Apr; 45(8):1165-71. PubMed ID: 15837244 [TBL] [Abstract][Full Text] [Related]
17. [Short and long-term therapeutic effects of rapamycin-eluting stent and paclitaxel-eluting stent in treatment of coronary disease with complicated lesions]. Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Liu HB; Xu B; Wu YJ; Yuan JQ; Chen J; Dai J; You SJ; Ma WH Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2183-6. PubMed ID: 16321180 [TBL] [Abstract][Full Text] [Related]
18. Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction. Karjalainen PP; Ylitalo A; Niemelä M; Kervinen K; Mäkikallio T; Pietilä M; Sia J; Tuomainen P; Nyman K; Airaksinen KE Ann Med; 2009; 41(8):599-607. PubMed ID: 19701826 [TBL] [Abstract][Full Text] [Related]
19. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. Lansky AJ; Costa RA; Mooney M; Midei MG; Lui HK; Strickland W; Mehran R; Leon MB; Russell ME; Ellis SG; Stone GW; J Am Coll Cardiol; 2005 Apr; 45(8):1180-5. PubMed ID: 15837246 [TBL] [Abstract][Full Text] [Related]
20. Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries. Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Liu HB; Xu B; Wu YJ; Yuan JQ; Chen J; Dai J; You SJ; Ma WH Chin Med J (Engl); 2006 Jan; 119(1):21-5. PubMed ID: 16454977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]